Results 21 to 30 of about 43,523 (262)

Awareness and acceptability of rotavirus vaccine among mothers of under-five children attending children outpatient clinic of ekiti state university teaching hospital

Nigerian Journal of Medicine, 2020
Background: Diarrhoea diseases remain a major contributor to infant and under-five morbidity and mortality, particularly in developing countries. Administration of the rotavirus vaccine is one of the effective measures to prevent acute and severe forms ...
A O Babatola, T O Ojo, E O Ogundare, A B Ajite, I O Oluwayemi, I Wuraola, J O Fadare, O S Olatunya   +7 more
doaj   +1 more source

Advances in enteric disease vaccines: from innovation to implementation [PDF]

, 2014
The Seventh International Conference on Vaccines for Enteric Diseases Bangkok, Thailand, 6–8 November 2013 Hosting 222 participants from more than 25 countries, the Seventh International Conference on Vaccines for Enteric Diseases (VED 2013) displayed ...
Parker, EPK
core   +1 more source

Rotavirus gastroenteritis in children hospitalized in northeastern Poland in 2006–2020: Severity, seasonal trends, and impact of immunization

International Journal of Infectious Diseases, 2021
Objectives: The introduction of the rotavirus vaccine in 2006 significantly reduced childhood incidence of acute gastroenteritis (AGE) worldwide. The rotavirus vaccine was included in Poland’s national immunization program in 2021.
Kacper Toczylowski, Katarzyna Jackowska, Dawid Lewandowski, Sandra Kurylonek, Marlena Waszkiewicz-Stojda, Artur Sulik   +5 more
doaj   +1 more source

Rotavirus Vaccines

Indian Journal of Medical Microbiology, 2006
Rotavirus, the most common cause of severe diarrhea and a leading cause of mortality in children, has been a priority target for vaccine development for the past several years. The first rotavirus vaccine licensed in the United States was withdrawn because of an association of the vaccine with intussusception.
openaire   +3 more sources

Rotavirus vaccine and health-care utilization for rotavirus gastroenteritis in Tsu City, Japan

Western Pacific Surveillance and Response, 2016
Background: Rotavirus vaccines were introduced in Japan in November 2011. We evaluated the subsequent reduction of the health-care burden of rotavirus gastroenteritis.
Kazutoyo Asada, Hajime Kamiya, Shigeru Suga, Mizuho Nagao, Ryoji Ichimi, Takao Fujisawa, Masakazu Umemoto, Takaaki Tanaka, Hiroaki Ito, Shigeki Tanaka, Masaru Ido, Koki Taniguchi, Toshiaki Ihara, Takashi Nakano   +13 more
doaj   +1 more source

Bivalent rotavirus VP4∗ stimulates protective antibodies against common genotypes of human rotaviruses

iScience, 2022
Summary: Non-replicating rotavirus vaccines are an alternative strategy to improve the efficacy and safety of rotavirus vaccines. The spike protein VP4, which could be enzymatically cleaved into VP8∗ and VP5∗, is an ideal target for the development of ...
Guoxing Luo, Yuanjun Zeng, Han Yang, Yijian Li, Lianwei Yang, Cao Li, Feibo Song, Shiyin Zhang, Tingdong Li, Shengxiang Ge, Jun Zhang, Ningshao Xia   +11 more
doaj   +1 more source

The laboratory test procedure to confirm rotavirus vaccine infection in severe complex immunodeficiency patients [PDF]

Osong Public Health and Research Perspectives, 2021
The rotavirus vaccine is a live vaccine, and there is a possibility of infection by the virus strain used in the vaccine. We investigated the process of determining whether an infection was caused by the vaccine strain in a severe complex ...
Su-Jin Chae, Seung-Rye Cho, Wooyoung Choi, Myung-Guk Han, Deog-Yong Lee   +4 more
doaj   +1 more source

Recombinant monovalent llama-derived antibody fragments (VHH) to rotavirus VP6 protect neonatal gnotobiotic piglets against human rotavirus-induced diarrhea [PDF]

, 2013
Group A Rotavirus (RVA) is the leading cause of severe diarrhea in children. The aims of the present study were to determine the neutralizing activity of VP6-specific llama-derived single domain nanoantibodies (VHH nanoAbs) against different RVA strains ...
Alvarado, Carmen, Bok, Karin, Bok, Marina, Chattha, Kuldeep S., Escribano, José M., Fernández, Fernando, Garaicoechea, Lorena Laura, Gómez Sebastián, Silvia, Lasa, Rodrigo, Nuñez, Carmen, Parreño, Gladys Viviana, Saif, Linda J., Vega, Celina Guadalupe, Vlasova, Anastasia N., Wigdorovitz, Andrés   +14 more
core   +3 more sources

A decade of experience with rotavirus vaccination in the United States – vaccine uptake, effectiveness, and impact

Expert Review of Vaccines, 2018
Introduction: Prior to 2006, nearly every U.S. child was infected with rotavirus by 5 years of age, and rotavirus was the leading cause of severe childhood gastroenteritis.
Talia Pindyck, Jacqueline E Tate, Umesh D Parashar   +2 more
doaj   +1 more source

Effectiveness of rotavirus vaccine in the prevention of diarrhoeal diseases among children under age five years in Kavango East and West Regions, Namibia

Journal of Public Health in Africa, 2021
Background: Diarrheal diseases due to rotavirus infection contribute greatly to morbidity and mortality rates of babies and young children in many developing countries.
Emmanuel Magesa, Marian Sankombo, Fillipine Nakakuwa   +2 more
doaj   +1 more source